HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BXI-72

structure in first source

Also Known As:

NSC334072

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - BXI-72: 2

Experts

1.	Deng, Xingming: 2 articles (12/2017 - 09/2013)
2.	Barrott, Jared J: 1 article (12/2017)
3.	Burrell, Lance D: 1 article (12/2017)
4.	Cannon-Albright, Lisa A: 1 article (12/2017)
5.	Capecchi, Mario R: 1 article (12/2017)
6.	Jones, Kevin B: 1 article (12/2017)
7.	Nollner, Dakota: 1 article (12/2017)
8.	Pozner, Amir: 1 article (12/2017)
9.	Smith-Fry, Kyllie: 1 article (12/2017)
10.	Susko, Asia M: 1 article (12/2017)

Related Diseases

1.	Lung Neoplasms (Lung Cancer) 09/01/2013 - "BXI-72 overcomes acquired radioresistance of lung cancer. " 09/01/2013 - "Importantly, BXI-61 and BXI-72 exhibit more potent efficacy against human lung cancer than ABT-737 but less degree in platelet reduction in vivo. "
2.	Synovial Sarcoma (Synovioma) 12/01/2017 - "However, targeting BCLxL in human and mouse synovial sarcoma with the small molecule BH3 domain inhibitor, BXI-72, achieved significant cytoreduction and increased apoptotic signaling. "

Related Drugs and Biologics

1.	BXI-61
2.	ABT-737